ACHILLION PHARMACEUTICALS INC 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Aug 19, 2014
Insider Transaction Report
Form 4
Deshpande Milind
EVP and CSO
Transactions
- Sale
Common Stock
2014-08-18$10.00/sh−16,250$162,500→ 0 total - Exercise/Conversion
Common Stock
2014-08-18$1.05/sh+15,950$16,748→ 15,950 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-08-18−15,950→ 0 totalExercise: $1.05Exp: 2018-12-15→ Common Stock (15,950 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-08-18−124,424→ 75,576 totalExercise: $3.10Exp: 2020-12-16→ Common Stock (124,424 underlying) - Exercise/Conversion
Common Stock
2014-08-18$4.00/sh+16,250$65,000→ 16,250 total - Sale
Common Stock
2014-08-18$10.00/sh−15,950$159,500→ 0 total - Exercise/Conversion
Common Stock
2014-08-18$3.28/sh+60,000$196,800→ 60,000 total - Exercise/Conversion
Common Stock
2014-08-18$3.10/sh+124,424$385,714→ 124,424 total - Sale
Common Stock
2014-08-18$10.00/sh−124,424$1,244,240→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-08-18−16,250→ 0 totalExercise: $4.00Exp: 2015-12-20→ Common Stock (16,250 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-08-18−60,000→ 0 totalExercise: $3.28Exp: 2019-12-18→ Common Stock (60,000 underlying) - Sale
Common Stock
2014-08-18$10.00/sh−60,000$600,000→ 0 total
Footnotes (4)
- [F1]This option was granted on December 20, 2005 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
- [F2]This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
- [F3]This option was granted on December 18, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
- [F4]This option was granted on December 16, 2010 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.